Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer

Int Urogynecol J Pelvic Floor Dysfunct. 2007 Nov;18(11):1379-80. doi: 10.1007/s00192-007-0368-y. Epub 2007 Apr 17.

Abstract

Dextranomer/hyaluronic acid copolymer (Zuidex(R)) is a new bulking agent. There is little data about the complications of using this substance as urethral bulking agent for the treatment of urinary stress incontinence. We are presenting a 59-year-old female patient who developed a suburethral mass and urinary retention after zuidex urethral injection. A stepwise approach for treatment was followed. Complete excision of the mass was the only curative procedure that succeeded.

Publication types

  • Case Reports

MeSH terms

  • Dextrans / administration & dosage*
  • Dextrans / adverse effects*
  • Female
  • Humans
  • Hyaluronic Acid / administration & dosage*
  • Hyaluronic Acid / adverse effects*
  • Injections
  • Magnetic Resonance Imaging
  • Middle Aged
  • Urethra / surgery*
  • Urinary Incontinence, Stress / pathology*
  • Urinary Incontinence, Stress / surgery*

Substances

  • Dextrans
  • dextranomer
  • Hyaluronic Acid